These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2813809

  • 1. Determination of plasma haloperidol concentrations by radioreceptor assay in schizophrenia: clinical utility.
    Santos JL, Ramos JA, Prieto P, Almoguera I, Vazquez C, Rubio ME, Cabranes JA.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):917-25. PubMed ID: 2813809
    [Abstract] [Full Text] [Related]

  • 2. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC, Baumgartner R, Misra CH, Mauldin M, Shvartsburd A, Ho BT, DeJohn C.
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia.
    Santos JL, Cabranes JA, Vazquez C, Fuentenebro F, Almoguera I, Ramos JA.
    Biol Psychiatry; 1989 Aug; 26(4):381-8. PubMed ID: 2669981
    [Abstract] [Full Text] [Related]

  • 5. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC, Vroulis G, Shvartsburd A, Allen R, Lewis N, Schoolar JC, Chojnacki M, Johnson R.
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Possible interference by the reduced haloperidol metabolite with the radioimmunoassay and radioreceptor assay of blood haloperidol.
    Korpi ER, Ko GN, Phelps BH, Wyatt RJ.
    J Clin Psychopharmacol; 1984 Dec; 4(6):332-5. PubMed ID: 6512001
    [Abstract] [Full Text] [Related]

  • 14. Prolactin response to single and multiple doses of haloperidol in schizophrenic patients.
    Ravichandran GK, Lu RB, Shvartsburd A, Misra CH, Ho BT, Kahn M, Smith RC.
    Psychiatry Res; 1984 Jan; 11(1):61-9. PubMed ID: 6584932
    [Abstract] [Full Text] [Related]

  • 15. Haloperidol plasma level after a test dose as predictor for the clinical response to treatment in acute schizophrenic patients.
    Louza Neto MR, Müller-Spahn F, Rüther E, Scherer J.
    Pharmacopsychiatry; 1988 Sep; 21(5):226-31. PubMed ID: 3227054
    [Abstract] [Full Text] [Related]

  • 16. Serum haloperidol concentrations and clinical response in acute psychosis.
    Miller DD, Hershey LA, Duffy JP, Abernethy DR, Greenblatt DJ.
    J Clin Psychopharmacol; 1984 Dec; 4(6):305-10. PubMed ID: 6511996
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The relationship of haloperidol concentrations to therapeutic response.
    Perry PJ, Pfohl BM, Kelly MW.
    J Clin Psychopharmacol; 1988 Feb; 8(1):38-43. PubMed ID: 3350997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.